By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    An Expert’s Guide To Building and Improving Endurance
    June 30, 2022
    medical assistants
    What Do Medical Assistants Do On a Day to Day Basis?
    April 5, 2022
    superfoods to help with prostate health
    10 Healthy Foods That Can Help Protect Your Prostate
    August 29, 2022
    Latest News
    Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
    July 20, 2025
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    pfizer and clinical data transparency
    Pfizer to Expand Clinical Trial Data Access, Takes Step Toward Transparency
    December 6, 2013
    Improving Healthcare Services And Management Through Tech Integration
    June 9, 2020
    obamacare and the uninsured
    Why Hospitals Are Still Gouging the Uninsured
    January 7, 2014
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Finally: An FDA (Draft) Guidance for Social Media in Medical Marketing
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Finally: An FDA (Draft) Guidance for Social Media in Medical Marketing
BusinesseHealthFinancePolicy & LawSocial Media

Finally: An FDA (Draft) Guidance for Social Media in Medical Marketing

Chen Sirkis
Chen Sirkis
Share
9 Min Read
SHARE

FDA draft social media guidance for pharma

Contents
FDA Social Media Guidance: Four years in the makingAbout the FDA social media (draft) guidanceWhich interactive promotional media requires postmarketing submissions?Firm responsibility of an employee-generated content or an agent who is acting on behalfThis is only the beginning

FDA draft social media guidance for pharma

FDA Social Media Guidance: Four years in the making

Four years have passed since the first hearing about the use of social media for medical marketing. A year has passed since the releasing of information about social media guidance for medical companies (unsolicited requests). Thus, it is time for the “real deal” to emerge. The FDA has finally released a comprehensive guidance on this topic (hurrah!).

The good news (1): Medical devices firms are off the hook (for now). However, while only covering drugs and biologics at this stage, medical devices firms need to stay attentive to the pulse of the industry, implementing in their social media guidelines whatever is appropriate.

More Read

medical supplies
Disruption in the Medical Supplies Business: B2B eCommerce is the Prevention and the Cure
The Innovation Center Will Now Demonstrate
Five Reasons Why Physicians Need to Use Social Media
HIT Employment Models: 1099, W2 Hourly or Salaried, Which Is Right For You?
Australian Providers Now Have Access to TotalExam

The good news (2): Firms are only responsible for the content that they create or influence. Sounds trivial, right? But the fact of the matter is that pharma firms were hesitant to engage in social media because of the undefined boundaries of responsibility and accountability.

This guideline doesn’t answer all of the questions or address all of the shortcomings, but it is a start.

About the FDA social media (draft) guidance

Titled “Guidance for Industry Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics,” this 10-page guidance draft is intended to describe the FDA’s current thinking about how manufacturers, packers, and distributors should act with regards to the use of interactive promotional media for their FDA-approved products.

The guide stipulates the responsibility of a manufacturer regarding promotional content. Promotional content is not limited to the material prepared and promoted by the pharma company on its own; indeed, it extends to companies operating on its behalf, as well. Accountability is determined according to the level of influence or control over the product’s promotional activity or communication in whole or in part.

The guidance is short yet comprehensive. It covers the use of interactive promotional media, which includes modern social media tools and technologies that often allow for real-time communications and interactions (e.g., blogs, microblogs, social networking sites, online communities, and live podcasts) that medical firms use to promote drugs or biologics.

Which interactive promotional media requires postmarketing submissions?

All materials used for promoting a product on sites that the medical company owns and influences are required to be submitted to the agency. Firms are responsible for submitting materials to the FDA, even in instances in which the influence is limited in scope, such as in cases where it collaborates with publishers on editorials, previews, and so forth (UCG means User Generated Content).

Example 1: A firm provides on its product website an online forum that gives users the opportunity to post comments about the use of its product. In this case, the firm is responsible for submitting to FDA the product website to meet the postmarketing submission requirements because the firm created, owns, or operates the website.

If a firm only provides financial support and has no influence on the site, then it has no obligation to submit the promotional materials to the FDA. Additionally, if it is merely providing promotional materials to a third-party site but does not direct the placement of the promotion within the site and has no other control or influence on that site, the firm is responsible only for the content it places there and, thus, is responsible only for submitting to the FDA any promotional content that was disseminated on that site.

Example 2: A firm does not have any control of, or influence on, information on an independent third-party site but chooses to promote its product on this site (e.g., by providing specific promotional content such as firm-initiated UGC). In this situation, to meet postmarketing submission requirements, the firm is responsible for submitting to FDA the promotional content it provided to the site.
 
Example 3: A firm makes suggestions on the placement of its promotional messages on an independent third-party site. Because the firm influenced the placement of its promotion within the third-party site, the firm is responsible for submitting to FDA the promotion, along with the surrounding pages, to adequately provide context to facilitate the review of the third-party site, in order to fulfill the postmarketing submission requirements.

Firm responsibility of an employee-generated content or an agent who is acting on behalf

A firm is responsible for the content generated by its employees or any agents acting on behalf of the firm who promote the firm’s product. This includes a medical science liaison or paid speaker (for example, a key opinion leader) acting on the firm’s behalf, as well as comments on a third-party site about the firm’s product. The firm is responsible for the content that its employee or agent provides. A firm is also responsible for the content on a blogger’s site if the blogger is acting on behalf of the firm.

Example 4: A sales representative acting on behalf of a firm posts comments about the innovative release mechanism of the firm’s product on an independent third-party site. Because the sales representative is acting on behalf of the firm, the firm is responsible for submitting the comments to FDA to meet the postmarketing submission requirements.
 
Example 5: A representative of a firm, such as a blogger paid by the firm, maintains a blog about the firm’s product. The firm is responsible for submitting the blog to FDA to meet the postmarketing submission requirements. FDA recommends that a firm be transparent in disclosing its involvement on a site by clearly identifying the UGC and communications of its employees or third parties acting on behalf of the firm. This could be achieved by inclusion of the firm’s identifier (e.g., name or logo) as part of the communication. However, a firm generally is not responsible for UGC that is truly independent of the firm (i.e., is not produced by, on behalf of, or prompted by the firm in any particular). FDA will not ordinarily view UGC on firm-owned or firm-controlled venues such as blogs, message boards, and chat rooms as promotional content on behalf of the firm as long as the user has no affiliation with the firm and the firm had no influence on the UGC.

This is only the beginning

All in all, the guidance relays how a drug manufacturer would do in the offline arena and extends it to marketing in the interactive healthcare social media environment. The main issue here for a firm is the need to have a tighter control over its marketing. While in the past, it was the firm’s marketing communications department that had the monopoly over the company’s medical marketing materials, now, each employee—or individual even partially sponsored by the company—is potentially a creator and distributor of promotional content. This is obviously more difficult for the medical firm to control.

TAGGED:FDA
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

botox certification
Help Improve People’s Skin Health Via Botox Certification
Skin Specialties
July 22, 2025
Telemedicine Apps
Why Custom Telemedicine Apps Outperform Off‑the‑Shelf Solutions
Health
July 20, 2025
Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025

You Might also Like

Providers: Shifting Landscape and Mindset

April 8, 2014
GeriatricsHealth careHome HealthWellness

Take These 4 Important Steps For Healthy And Happy Aging

February 15, 2019

How To Find a Job in Home Health Care, Elder Care, or Aging Using Social Media

July 12, 2012
pharma and rewards
BusinessFinance

How Pharma Can Meet Consumer Expectations

October 21, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?